{"entity":{"type":"insider","cik":"0001618060","url":"/insider/0001618060","json_url":"/insider/0001618060.json","name":"Becker Marc A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2020-08-19","last":"2023-02-16","span_basis":"filed_date"},"name_variants":[{"name":"Becker Marc A.","source":"filing","n_filings":8,"first_seen":"2020-08-19","last_seen":"2023-02-16"}],"transactions":[{"id":7896455,"accession":"0001209191-23-009947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-009947","line_url":"/filing/0001209191-23-009947#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3762.0,"shares_display":"3,762","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":31337.46,"total_display":"31,337.46","total_whole":"31,337","shares_owned_after":123863.0,"shares_owned_after_display":"123,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-16","scope":"insider"},{"id":8605442,"accession":"0001209191-23-005619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005619","line_url":"/filing/0001209191-23-005619#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8493.0,"shares_display":"8,493","price_per_share":8.35,"price_display":"8.35","price_state":"stated","total_value":70916.55,"total_display":"70,916.55","total_whole":"70,917","shares_owned_after":127625.0,"shares_owned_after_display":"127,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"},{"id":8461256,"accession":"0001209191-23-002550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002550","line_url":"/filing/0001209191-23-002550#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2893.0,"shares_display":"2,893","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":20974.25,"total_display":"20,974.25","total_whole":"20,974","shares_owned_after":136118.0,"shares_owned_after_display":"136,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":6178048,"accession":"0001209191-22-010071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-010071","line_url":"/filing/0001209191-22-010071#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3762.0,"shares_display":"3,762","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":11586.96,"total_display":"11,586.96","total_whole":"11,587","shares_owned_after":139011.0,"shares_owned_after_display":"139,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-16","scope":"insider"},{"id":6242351,"accession":"0001209191-22-002398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002398","line_url":"/filing/0001209191-22-002398#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2894.0,"shares_display":"2,894","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":9260.8,"total_display":"9,260.80","total_whole":"9,261","shares_owned_after":61173.0,"shares_owned_after_display":"61,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4896058,"accession":"0001209191-21-051817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051817","line_url":"/filing/0001209191-21-051817#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7304.0,"shares_display":"7,304","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":23957.12,"total_display":"23,957.12","total_whole":"23,957","shares_owned_after":64067.0,"shares_owned_after_display":"64,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":4416382,"accession":"0001209191-21-011613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011613","line_url":"/filing/0001209191-21-011613#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3763.0,"shares_display":"3,763","price_per_share":7.32,"price_display":"7.32","price_state":"stated","total_value":27545.16,"total_display":"27,545.16","total_whole":"27,545","shares_owned_after":71371.0,"shares_owned_after_display":"71,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":3116295,"accession":"0001209191-20-047575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047575","line_url":"/filing/0001209191-20-047575#line-1","is_derivative":false,"issuer_cik":"0001367920","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001367920","owner_cik":"0001618060","owner_name":"Becker Marc A.","owner_display_name":"Becker Marc A.","owner_url":"/insider/0001618060","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2875.0,"shares_display":"2,875","price_per_share":10.24,"price_display":"10.24","price_state":"stated","total_value":29440.0,"total_display":"29,440.00","total_whole":"29,440","shares_owned_after":53434.0,"shares_owned_after_display":"53,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367920","name":"CONCERT PHARMACEUTICALS, INC.","url":"/issuer/0001367920","role":"Officer (Chief Financial Officer)","n_filings":8,"first_seen":"2020-08-19","last_seen":"2023-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618060","retrieved_at":"2026-08-22T05:05:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}